Is Health diplomacy keeping pace with global health developments? implications for access to medicines strategies in the post-2015 MDG framework
Ski, Samantha; Kiddell-Monroe, Rachel; Sherry, James M.
Journal of Health Diplomacy
; 1(1): [22], 2013.
Artículo en Inglés | BDS | ID: biblio-832195
Documentos relacionados
Gaps and opportunities in sustainable medicines use in resource limited settings: A situational analysis of Uganda.
Acceptability of a short list of essential medicines to patients and prescribers: Multimethod study.
National medicines policy development, Saudi Arabia.
A cross-sectional analysis of falsified, counterfeit and substandard medicines in a low-middle income country.
Access to Controlled Medicines in Low-Income Countries: Listening to Stakeholders in the Field.
Framing access to essential medicines in the context of Universal Health Coverage: a critical analysis of health sector strategic plans from eight countries in the WHO African region.
Antiseizure medications in the World Health Organization list of "essential medicines".
Prices, availability, and affordability of national essential medicines in public primary hospitals: A cross-sectional survey in poverty-stricken rural areas in China.
In which developing countries are patents on essential medicines being filed?
Facteurs individuels associés à l'usage irrationnel des médicaments essentiels génériques, Burkina Faso.